Laura D'Andrea Tyson

Professor, Haas School of Business at the University of California, Berkeley

Dr. Tyson is a professor at the Haas School of Business at the University of California, Berkeley. Previously, she was dean of London Business School from 2002 to 2006. She was formerly Bank America dean of the Walter A Haas School of Business at the University of California, Berkeley, where she earlier held the University’s Class of 1939 Chair in economics and was director of its Institute of International Studies. Dr. Tyson was the national economic adviser to President Clinton and head of the National Economic Council. She served on the President’s National Security and Domestic Policy Councils, and was the first woman to hold the post of chairman of the White House Council of Economic Advisers. She was also research director of the Berkeley Roundtable on the International Economy. She has written extensively on competitiveness and trade, including Who’s Bashing Whom? Trade Conflict in High Technology Industries. She is a member of the board of directors of SBC Communications, Morgan Stanley, Kodak, Human Genome Sciences, LECG, and The Brookings Institution. She is an economic viewpoint columnist for Business Week. Dr. Tyson is based in Berkeley, CA.

Top Stories on CFR

Russia

Liana Fix, a fellow for Europe at CFR, and Thomas Graham, a distinguished fellow at CFR, sit down with James M. Lindsay to discuss the future of U.S. policy toward Russia and the risks posed by heightened tensions between two nuclear powers. This episode is the first in a special TPI series on the U.S. 2024 presidential election and is supported by the Carnegie Corporation of New York.

Terrorism and Counterterrorism

Violence around U.S. elections in 2024 could not only destabilize American democracy but also embolden autocrats across the world. Jacob Ware recommends that political leaders take steps to shore up civic trust and remove the opportunity for violence ahead of the 2024 election season.

China

Those seeking to profit from fentanyl and governments seeking to control its supply are locked in a never-ending competition, with each new countermeasure spurring further innovation to circumvent it.